The novel treatment of this peptide represents a major breakthrough in the management of type 2 diabetes. Unlike existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide378346.is-blog.com/49047393/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment